Flagship V VentureLabs Rx Fund, L.P. 13D/13G Filings for OMEGA THERAPEUTICS INC (OMGAQ)

Flagship V VentureLabs Rx Fund, L.P. 13D and 13G filings for OMEGA THERAPEUTICS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-05
4:40 pm
Purchase
2025-02-03 13D OMEGA THERAPEUTICS INC
OMGAQ
Flagship V VentureLabs Rx Fund, L.P. 29,225,579
52.800%
29,225,579increase
(New Position)
Filing